Mesa Science Associates to Present on Canine Epilepsy at The Kansas City Animal Health Corridor Annual Investors Meeting
Mesa Science Associates Inc. (MSA) announced
today that MSA has been invited to present their work on Canine Epilepsy at the
Kanas City Animal Health Corridor annual meeting to be held in Kansas City the
week of August 26, 2019. MSA Principal Tim Warneke will present the MSA Canine
Project in a podium presentation aimed at investors interested in the animal
health space.
MSA is a virtual company who until now
has offered pharmaceutical consulting and management services to investigators
who are developing new uses for old drugs and for those developing new
pharmaceutical entities. MSA currently serves product developers from private
companies as well as NIH sponsored investigators.
The Caine project is the first product
to be owned by and developed under the MSA flag. The company is seeking funding
to complete the Canine Project which is in advanced development. MSA principals
decided to pursue this project after their research into human epilepsy
revealed that annually there are over three million dogs in the U.S. suffering
seizures with like numbers occurring in Europe. The company also discovered
that there is no FDA approved treatment for canines that can be easily
administered at home or away from professional veterinary facilities.
Epileptic seizures are a medical emergency for both humans and canines
requiring rapid treatment to protect the brain from serious injury. An
emergency visit to a vet or hospital is costly in both time and dollars. The
MSA concept is to obtain FDA approval for a drug in a device that will provide
the pet owner with an easy and effective way to help break the seizure as soon
as possible after it occurs and to help delay the onset of future seizures.
This approach will provide the owner a cost-effective treatment that is timely
and easy for the lay caregiver to administer.
Mr. Michael Mesa, President of MSA
stated that “the company is excited by this project as it will hopefully extend
the life of beloved pets and provide comfort to the pet owner who will be able
to actively treat this dangerous condition in their own home. This, we
believe, will result in an improved quality of life for both the dog and the
owner.”
MSA team members strong background in
the development of products aimed at the emergency treatment of human epilepsy
helped in the transition to canines. Mr. Mesa in a former position led the
development of the autoinjector product used in the highly successful NIH
Rampart Study. The Rampart Study showed that a drug in an autoinjectors could
provide an effective out of hospital treatment for patients experiencing active
seizures. Mr. Mesa and Mr. Warneke, while both at King Pharmaceuticals,
collaborated on The RESCUE Study project, that was aimed at providing at-home-treatment of acute repetitive
seizure.
Written By:
Michael Mesa, CEO of Mesa Science Associates Inc. (MSA)
Share this news:
Business Development for Frederick!
For scientists and entrepreneurs who want tough love from proven growth fanatics to confidently take the next step.
Email Sign-Up
Get Connected! Stay up to date on FITCI Activities and Events.
Stay up to date on our newest products and services.
Your information is 100% safe. We hate spam too.
U.S. DEPARTMENT OF COMMERCE ANNOUNCES 51 “BUILD TO SCALE” GRANTS TOTALING $47 MILLIONTO FUEL INNOVATION AND TECH-BASED ECONOMIC DEVELOPMENT
Contact: EDA Public Affairs Department, (202) 482-4085
October 5, 2022
WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced that the Department’s Economic Development Administration (EDA) is awarding 51 “Build to Scale” grants – totaling $47 million – to organizations that support technology entrepreneurs, catalyze innovation and fuel economic growth.
EDA’s “Build to Scale” program provides annual grants that aim to accelerate technology entrepreneurship by increasing inclusive access to entrepreneurial support and startup capital. The 2022 awardees will leverage an additional $48 million in matching funds from a variety of private and public sector sources. These EDA investments support advanced manufacturing, bioscience, clean energy and blue economy clusters in regions throughout the United States.
"Strengthening technology ecosystems are a critical key to the Biden Administration's efforts to build a stronger America,” said Secretary of Commerce Gina Raimondo. “Innovation and entrepreneurship have long been keys to American success and will continue to strengthen our collective economic and national security, as well as individual prosperity and well-being.”
"EDA is proud to partner with this year's 'Build to Scale' grantees as they invest in entrepreneurs and create equitable access to capital in their communities," said Assistant Secretary of Commerce for Economic Development Alejandra Y. Castillo. "These projects will give the next generation of industry-leading companies a seminal boost that will result in job creation and private investment – potentially transforming a regional economy and creating economic opportunity beyond what we can foresee.”
The 2022 Build to Scale program was comprised of two competitions––the Venture Challenge and the Capital Challenge. The Venture Challenge supports programs that enable high-growth technology entrepreneurship and foster inclusive access to proven entrepreneurship support models. The Capital Challenge increases access to capital in communities where risk capital is in short supply by providing operational support for early-stage investment funds, networks, and training programs that focus on both traditional and hybrid equity-based financing.
About the U.S. Economic Development Administration (www.eda.gov)
The mission of the U.S. Economic Development Administration (EDA) is to lead the federal economic development agenda by promoting competitiveness and preparing the nation's regions for growth and success in the worldwide economy. An agency within the U.S. Department of Commerce, EDA invests in communities and supports regional collaboration in order to create jobs for U.S. workers, promote American innovation, and accelerate long-term sustainable economic growth.
